Unfortunately, Amyloidosis Research Consortium Inc. has limited available public data.
Create an account for free to request more data.
Mission
Accelerating the development of advanced diagnostic tools and effective treatments for systemic amyloidosis through collaboration and innovation.
Basic Information
Tax-Exempt
Founded in
2015
EIN
47-2589708
Total Assets
$2.516 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 1 of 1 goals
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
57
40
/100
Program Expense Ratio
69.04%
8
/20
Program Revenue Growth
-100.00%
2
/20
Leverage Ratio
0.1196
18
/20
Working Capital Ratio
1.04
10
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 2.22M | 98.20% |
| Program Services | 0 | 0.00% |
| Investment Income | 38.69K | 1.71% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 1.913K | 0.08% |
| Total Revenue | 2.26M | 100.00% |
Related Nonprofits
Cystinosis Research Foundation
Med Research
Disease ResearchOxfendazole Development Group
Med Research
Disease ResearchHaleys Heroes Foundation
Med Research
Disease ResearchAmyloidosis Research Consortium Inc.
Med Research
Disease ResearchLysosomal and Rare Disorders Research and Treatment Center Inc.
Med Research
Disease Research